Ten EMA initiatives will strengthen clinical research in Europe
The framework conditions for clinical research in Europe have proved challenging and difficult, the EMA says. With ten new initiatives, the European health authority wants to change how trials are designed, initiated and conducted. Industry association Lif welcomes the changes.
With ten new initiatives, the European health authority wants to strenghten clinical research in Europe | Photo: Bioneer / PR
by ALBERT RØNNING-ANDERSSON, translated by daniel pedersen
Clinical trials are a necessity for the development of drugs, medical equipment, new treatments and the life science industry at large.
A UBS analyst believes increased competition on the obesity market combined with high prices will lead to Novo’s rival, Eli Lilly, taking a bigger slice of the pie.